NovaXS Biotech Corp

CIK: 1946145DEIncorporated: 2021-01-11

Current Offering

$25,000
Target Amount
$1,235,000
Maximum Amount
2023-02-03
Deadline

Security Details

Type: Crowd SAFE (Simple Agreement for Future Equity)
Price per share: $1.00
Shares offered: 25,000+

Offering Costs

Cash commission: 6%
At the conclusion of the offering, the issuer shall pay a fee of six percent (6%) of the amount raised in the offering to the Intermediary.
Equity compensation: 2%
The Intermediary will also receive compensation in the form of securities equal to two percent (2%) of the total number of the securities sold in the offering.

Financial Reports

Offering via Republic

Offering History

As of 2022-12-05
Raising $25,000 -$1,235,000 via 25,000+ shares of crowd SAFE (Simple Agreement for Future Equity) at $1.00 per share
Deadline: 2023-02-03
Filing date2022-12-05
Current employees5
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$297,216
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$0.00
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$290,000
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$62,494.00
Net income prior fiscal year$0.00
Revenue most recent fiscal year$0.00
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$7,872
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$297,216
Total asset prior fiscal year$0.00

Company Information

Corporation
DE
2021-01-11

Latest Metrics

Employees5
Total Assets$297,216
Cash on Hand$297,216
Revenues$0.00
Net Income-$62,494.00

Crowdfunding Portals

This company is raising funds through this portal